DJIA 17,085.61 111.30 0.66%
NASDAQ 4,543.36 -5.87 -0.13%
S&P 500 1,978.01 -4.29 -0.22%
market minute promo

Impax Laboratories Inc. (NASDAQ: IPXL)

28.02 -0.17 (-0.60%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IPXL $28.02 -0.60%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $28.04
Previous Close $28.19
Daily Range $28.04 - $28.40
52-Week Range $19.67 - $31.04
Market Cap $2.0B
P/E Ratio 64.07
Dividend (Yield) $0.00 (0.0%)
Volume 11,724
Average Daily Volume 639,291
Current FY EPS $1.26

Sector

Healthcare

Industry

Drugs

Impax Laboratories Inc. (IPXL) Description

Impax Laboratories Inc. is a technology-based specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals utilizing its controlled-release and other in-house development. Website: http://www.impaxlabs.com/

News & Commentary Rss Feed

3 Biotech Stocks With Upcoming Catalysts

BioDelivery Sciences International, Keryx Biopharmaceuticals, and Pozen Inc. all have near-term regulatory catalysts. Which, if any, are worth keeping tabs on?

The Medicines Co.'s Angiomax Gets Favorable Court Ruling - Analyst Blog

Impax Announces Departure of Carole Ben-Maimon, M.D., President of Global Pharmaceuticals

Akorn (AKRX) Looks Good: Stock Adds 5.8% in Session - Tale of the Tape

Benzinga's Top Initiations

Can The Uptrend Continue for Impax Laboratories (IPXL)? - Tale of the Tape

3 Stocks Spiking on Unusual Volume

Impax Up, Set to Buy Tower Holdings & Lineage Therapeutics - Analyst Blog

RoundTable Healthcare Partners Announces Sale Of Tower Holdings, Inc. And Lineage Therapeutics Inc.

RoundTable Healthcare Partners Announces Sale Of Tower Holdings, Inc. And Lineage Therapeutics Inc. To Impax Laboratories, Inc.

Why Impax Laboratories (IPXL) Stock Is Spiking Today

Impax Laboratories Breaks Above 200-Day Moving Average - Bullish for IPXL

See More IPXL News...

IPXL's Top Competitors

IPXL $28.02 (-0.60%)
Current stock: IPXL
JNJ $105.23 (-0.31%)
Current stock: JNJ
NVS $91.49 (0.20%)
Current stock: NVS
RHHBY $36.94 (0.56%)
Current stock: RHHBY